Dr. Ann LaCasce
Medical Oncologist at Dana-Farber Cancer Institute/Brigham and Women’s Cancer Center’s Adult Lymphoma Program
Dr. LaCasce discusses current treatment options for mantle cell lymphoma (MCL) and new therapies on the horizon. Learn more about the latest MCL research, treatment options, clinical trials and her involvement with the Lymphoma Research Foundation (LRF).
Dr. Andre Goy
Chairman and Director of the John Theurer Cancer Center
Dr. Goy, Lymphoma Research Foundation (LRF) Scientific Advisory Board and Mantle Cell Lymphoma Consortium member, discusses current treatment options for mantle cell lymphoma and what is on the horizon. Learn more about what research is being conducted, potential new targeted therapies and the importance of clinical trials.
Dr. Leo Gordon
Abby and John Friend Professor of Cancer Research, Professor in Medicine and Director of the Lymphoma Program at the Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Centre of Northwestern University
Dr. Gordon, chair of the Lymphoma Research Foundation (LRF) Scientific Advisory Board and chair of the Mantle Cell Lymphoma Consortium, discusses current treatment options for mantle cell lymphoma and his involvement with LRF.
Dr. Brad Kahl
Skoronski Chair of Lymphoma Research at the University of Wisconsin School of Medicine and Public Health and Associate Director of Clinical Research at the UW Carbone Cancer Center
Dr. Kahl discusses current therapies for mantle cell lymphoma (MCL), as well as potential new treatment options, particularly those that could be used for patients who require maintenance therapy.
Dr. Mitchell Smith
Director of the Lymphoid Malignancy Program at the Cleveland Clinic
Dr. Smith discusses current and potential treatment options for mantle cell lymphoma and his involvement with the Lymphoma Research Foundation.
Dr. Peter Martin
Assistant Professor of Medicine; Division of Hematology and Oncology; New York-Presbyterian Hospital/Weill Cornell Medicine
Peter Martin, MD discusses mantle cell lymophoma (MCL), using stem cell transplantation in treating MCL, and shares advice for newly diagnosed and relapsed/refractory patients.